Selected research
Industry Research
Diagnostic Imaging Agent Industry Research Report 2026
Market perspective
The global Diagnostic Imaging Agent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Diagnostic Imaging Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Diagnostic Imaging Agent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Diagnostic Imaging Agent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Diagnostic Imaging Agent include GE HealthCare, Bracco Diagnostic, Guerbet, Abx Advanced Biochemical, Bayer AG, Blue Earth Diagnostics, Cardinal Health, Eli Lilly and Company and Lantheus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Diagnostic Imaging Agent market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diagnostic Imaging Agent Market by Company
GE HealthCare
Bracco Diagnostic
Guerbet
Abx Advanced Biochemical
Bayer AG
Blue Earth Diagnostics
Cardinal Health
Eli Lilly and Company
Lantheus
Mallinckrodt
Navidea
Yantai Dongcheng
Foshan Rui Diao Pharmaceutical
Jubilant Pharma Limited
Diagnostic Imaging Agent Segment by Type
Conjugated Imaging Agent
Metabolic Imaging Agent
Blood Flow and Blood Volume Imaging Agents
Diagnostic Imaging Agent Segment by Application
Neurological Disease
Gastrointestinal Disease
Heart Disease
Tumor
Diagnostic Imaging Agent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Imaging Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Imaging Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Imaging Agent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diagnostic Imaging Agent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diagnostic Imaging Agent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diagnostic Imaging Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Conjugated Imaging Agent
- Metabolic Imaging Agent
- Blood Flow and Blood Volume Imaging Agents
Applications
- Neurological Disease
- Gastrointestinal Disease
- Heart Disease
- Tumor
Companies covered
- GE HealthCare
- Bracco Diagnostic
- Guerbet
- Abx Advanced Biochemical
- Bayer AG
- Blue Earth Diagnostics
- Cardinal Health
- Eli Lilly and Company
- Lantheus
- Mallinckrodt
- Navidea
- Yantai Dongcheng
- Foshan Rui Diao Pharmaceutical
- Jubilant Pharma Limited
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diagnostic Imaging Agent Market Size (2021-2032)
- 2.2.2 Global Diagnostic Imaging Agent Sales (2021-2032)
- 2.2.3 Global Diagnostic Imaging Agent Market Average Price (2021-2032)
- 2.3 Diagnostic Imaging Agent by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Conjugated Imaging Agent
- 2.3.3 Metabolic Imaging Agent
- 2.3.4 Blood Flow and Blood Volume Imaging Agents
- 2.4 Diagnostic Imaging Agent by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Neurological Disease
- 2.4.3 Gastrointestinal Disease
- 2.4.4 Heart Disease
- 2.4.5 Tumor
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diagnostic Imaging Agent Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diagnostic Imaging Agent Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Diagnostic Imaging Agent Revenue of Manufacturers (2021-2026)
- 3.4 Global Diagnostic Imaging Agent Average Price by Manufacturers (2021-2026)
- 3.5 Global Diagnostic Imaging Agent Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diagnostic Imaging Agent, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diagnostic Imaging Agent, Product Type & Application
- 3.8 Global Manufacturers of Diagnostic Imaging Agent, Established Date
- 3.9 Global Diagnostic Imaging Agent Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GE HealthCare
- 4.1.1 GE HealthCare Company Information
- 4.1.2 GE HealthCare Business Overview
- 4.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
- 4.1.5 GE HealthCare Recent Developments
- 4.2 Bracco Diagnostic
- 4.2.1 Bracco Diagnostic Company Information
- 4.2.2 Bracco Diagnostic Business Overview
- 4.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
- 4.2.5 Bracco Diagnostic Recent Developments
- 4.3 Guerbet
- 4.3.1 Guerbet Company Information
- 4.3.2 Guerbet Business Overview
- 4.3.3 Guerbet Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
- 4.3.5 Guerbet Recent Developments
- 4.4 Abx Advanced Biochemical
- 4.4.1 Abx Advanced Biochemical Company Information
- 4.4.2 Abx Advanced Biochemical Business Overview
- 4.4.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
- 4.4.5 Abx Advanced Biochemical Recent Developments
- 4.5 Bayer AG
- 4.5.1 Bayer AG Company Information
- 4.5.2 Bayer AG Business Overview
- 4.5.3 Bayer AG Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
- 4.5.5 Bayer AG Recent Developments
- 4.6 Blue Earth Diagnostics
- 4.6.1 Blue Earth Diagnostics Company Information
- 4.6.2 Blue Earth Diagnostics Business Overview
- 4.6.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
- 4.6.5 Blue Earth Diagnostics Recent Developments
- 4.7 Cardinal Health
- 4.7.1 Cardinal Health Company Information
- 4.7.2 Cardinal Health Business Overview
- 4.7.3 Cardinal Health Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
- 4.7.5 Cardinal Health Recent Developments
- 4.8 Eli Lilly and Company
- 4.8.1 Eli Lilly and Company Company Information
- 4.8.2 Eli Lilly and Company Business Overview
- 4.8.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
- 4.8.5 Eli Lilly and Company Recent Developments
- 4.9 Lantheus
- 4.9.1 Lantheus Company Information
- 4.9.2 Lantheus Business Overview
- 4.9.3 Lantheus Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lantheus Diagnostic Imaging Agent Product Portfolio
- 4.9.5 Lantheus Recent Developments
- 4.10 Mallinckrodt
- 4.10.1 Mallinckrodt Company Information
- 4.10.2 Mallinckrodt Business Overview
- 4.10.3 Mallinckrodt Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
- 4.10.5 Mallinckrodt Recent Developments
- 4.11 Navidea
- 4.11.1 Navidea Company Information
- 4.11.2 Navidea Business Overview
- 4.11.3 Navidea Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Navidea Diagnostic Imaging Agent Product Portfolio
- 4.11.5 Navidea Recent Developments
- 4.12 Yantai Dongcheng
- 4.12.1 Yantai Dongcheng Company Information
- 4.12.2 Yantai Dongcheng Business Overview
- 4.12.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
- 4.12.5 Yantai Dongcheng Recent Developments
- 4.13 Foshan Rui Diao Pharmaceutical
- 4.13.1 Foshan Rui Diao Pharmaceutical Company Information
- 4.13.2 Foshan Rui Diao Pharmaceutical Business Overview
- 4.13.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
- 4.13.5 Foshan Rui Diao Pharmaceutical Recent Developments
- 4.14 Jubilant Pharma Limited
- 4.14.1 Jubilant Pharma Limited Company Information
- 4.14.2 Jubilant Pharma Limited Business Overview
- 4.14.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
- 4.14.5 Jubilant Pharma Limited Recent Developments
5 Global Diagnostic Imaging Agent Market Scenario by Region
- 5.1 Global Diagnostic Imaging Agent Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diagnostic Imaging Agent Sales by Region: 2021-2032
- 5.2.1 Global Diagnostic Imaging Agent Sales by Region: 2021-2026
- 5.2.2 Global Diagnostic Imaging Agent Sales by Region: 2027-2032
- 5.3 Global Diagnostic Imaging Agent Revenue by Region: 2021-2032
- 5.3.1 Global Diagnostic Imaging Agent Revenue by Region: 2021-2026
- 5.3.2 Global Diagnostic Imaging Agent Revenue by Region: 2027-2032
- 5.4 North America Diagnostic Imaging Agent Market Facts & Figures by Country
- 5.4.1 North America Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diagnostic Imaging Agent Sales by Country (2021-2032)
- 5.4.3 North America Diagnostic Imaging Agent Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Diagnostic Imaging Agent Market Facts & Figures by Country
- 5.5.1 Europe Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diagnostic Imaging Agent Sales by Country (2021-2032)
- 5.5.3 Europe Diagnostic Imaging Agent Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Diagnostic Imaging Agent Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diagnostic Imaging Agent Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diagnostic Imaging Agent Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diagnostic Imaging Agent Market Facts & Figures by Country
- 5.7.1 South America Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diagnostic Imaging Agent Sales by Country (2021-2032)
- 5.7.3 South America Diagnostic Imaging Agent Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Diagnostic Imaging Agent Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diagnostic Imaging Agent Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diagnostic Imaging Agent Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diagnostic Imaging Agent Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Diagnostic Imaging Agent Sales by Type (2021-2032)
- 6.1.1 Global Diagnostic Imaging Agent Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Diagnostic Imaging Agent Sales Market Share by Type (2021-2032)
- 6.2 Global Diagnostic Imaging Agent Revenue by Type (2021-2032)
- 6.2.1 Global Diagnostic Imaging Agent Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diagnostic Imaging Agent Revenue Market Share by Type (2021-2032)
- 6.3 Global Diagnostic Imaging Agent Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diagnostic Imaging Agent Sales by Application (2021-2032)
- 7.1.1 Global Diagnostic Imaging Agent Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Diagnostic Imaging Agent Sales Market Share by Application (2021-2032)
- 7.2 Global Diagnostic Imaging Agent Revenue by Application (2021-2032)
- 7.2.1 Global Diagnostic Imaging Agent Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diagnostic Imaging Agent Revenue Market Share by Application (2021-2032)
- 7.3 Global Diagnostic Imaging Agent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diagnostic Imaging Agent Value Chain Analysis
- 8.1.1 Diagnostic Imaging Agent Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diagnostic Imaging Agent Production Mode & Process
- 8.2 Diagnostic Imaging Agent Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diagnostic Imaging Agent Distributors
- 8.2.3 Diagnostic Imaging Agent Customers
9 Global Diagnostic Imaging Agent Analyzing Market Dynamics
- 9.1 Diagnostic Imaging Agent Industry Trends
- 9.2 Diagnostic Imaging Agent Industry Drivers
- 9.3 Diagnostic Imaging Agent Industry Opportunities and Challenges
- 9.4 Diagnostic Imaging Agent Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst